Hong Kong Healthtech Stock News

Maoyan Entertainment stock has drifted lower over the past three months, yet the latest half year numbers land with a very different message. The headline is a swing back into loss territory in H1 2026, with basic earnings per share moving to a loss of ¥0.02 and net income slipping into a loss of ¥27.6m, even as trailing 12 month profit and margins remain positive. For investors who bought into the recent profitability story, this setback in reported earnings, alongside a still modest...

Beijing North Star slipped to HK$0.71 at the close in Hong Kong, even though short term returns over the past week and month stayed slightly positive. The stock is priced at a steep discount to an analyst fair value estimate of HK$5.61, which keeps valuation front and center as investors digest fresh Q2 numbers. The headline from this earnings release is not the share price; it is the continued strain from heavy losses. Beijing North Star reported a Q2 loss of CNY 729.3m and trailing 12 month...

Sipai Health Technology stock has been quietly grinding higher in recent weeks, yet the latest earnings headline is focused on a sharp turn in profitability rather than the share price drift. After a stretch of losses, Sipai reported basic earnings per share of ¥0.07 for the first half of 2026 on revenue of ¥739.9m. That shift from loss to profit on a half-year view is the key development traders are weighing against a modestly valued stock that currently trades at about 0.6x sales. Is Sipai...

Bank of East Asia stock has quietly climbed about 24% over the past month, yet today’s H1 print shows why the market still feels divided. The main takeaway is not the share price; it is a solid profit haul sitting on top of a balance sheet that carries elevated non performing loans and relatively low coverage. Net income for the first half landed at HK$2,416 million with basic earnings per share of HK$0.91, while the net interest margin held at 1.85%. That mix gives investors a clearer...

Apex Ace Holding shares closed at HK$1.30 on Friday after a choppy few months, with the stock down 16.7% over the past week but still higher over one and three months. The market’s focus today is the earnings jump. Basic earnings per share for the first half of 2026 came in at HK$0.1271, on revenue of HK$4,972.8m. The short term move reflects nerves around volatility and debt coverage. The bigger story for long term holders is the very large earnings growth over the past year and a P/E of...

Chinese Estates Holdings went into this earnings day with a flat week and a weaker three month run, yet the stock closed at HK$1.08 as investors absorbed another loss making half. The headline is simple: H1 2026 showed higher revenue, but the story is dominated by red ink and a rich valuation. The company reported H1 2026 revenue of HK$133.8 million and a basic loss per share of HK$0.105. Over the past year Chinese Estates Holdings remained unprofitable and traded on a trailing P/S of 12.2x,...

China Power International Development closed at HK$2.76 on 21 August after a choppy few months, with the stock down about 21% over 90 days. Yet the latest half year results land with a different message. The headline is margin and profit pressure. Trailing net profit margin sits at 3% compared with 6.3% a year earlier, and earnings from continuing operations over the last twelve months are CNY 4,120.638m on revenue of CNY 52,997.865m. The market now has to decide whether today’s price still...

Chow Sang Sang Holdings International (SEHK:116) issued fresh earnings guidance for the six months to 30 June 2026, stating that profit attributable to owners is expected to be between HK$2,100 million and HK$2,200 million, compared with HK$910 million a year earlier. See our latest analysis for Chow Sang Sang Holdings International. Chow Sang Sang Holdings International has attracted attention after the earnings guidance, with the HK$15.8 latest share price sitting on strong recent momentum,...

Soundwill Holdings stock has barely moved over the past month, yet the latest earnings lay out a far more uncomfortable picture than the price suggests. The headline is simple: revenue for the first half of 2026 came in at HK$307.9m, while the company still reported a net loss of HK$484.5m. That keeps the last 12 months firmly loss making, with earnings from continuing operations also in the red. For a property group trading on a P/S ratio of 3.7x against a much cheaper sector, this...

Hanking Gold International stock closed at HK$3.60 on Friday after a strong run over the past month, yet the latest half year earnings land with a very different tone. Revenue for H1 2026 came in at C¥911.6m and the company reported a net loss of C¥52.0m, which pulls basic earnings per share into a loss as well. Short term traders are reacting to price momentum, while long term investors are more likely to focus on the squeeze in profitability and the pressure this puts on an already premium...

CK Asset Holdings (SEHK:1113) drew fresh attention after its half year 2026 earnings and dividend update, which highlighted higher sales, net income and earnings per share compared with the same period a year earlier. See our latest analysis for CK Asset Holdings. The half year update arrived after a mixed price pattern for CK Asset Holdings, with the share price up 5.16% over the past week but down 7.49% over the past three months. At the same time, the year to date share price return of...

Yonghe Medical Group stock closed at HK$2.49 on Friday after a flat week and a strong 30 day rebound, yet the real story sits in the earnings line. The market is still pricing a low P/E of 8.8x for a healthcare provider that has moved from multi year losses to a trailing twelve month profit of CNY 121.3 million. The headline from this half year release is clear. Profitability is no longer a theory. Basic earnings per share for H1 2026 came in at CNY 0.15 and the recent return to the black now...

NetEase went into this earnings print with the stock up around 11% over the last three months and trading on a premium P/E, priced as one of the higher quality plays in Hong Kong gaming. The market has been paying up for a clean balance between growth and profitability. Today's headline is that profit quality, not just top line, did the heavy lifting. Q2 revenue came in at RMB 30.1b with games again carrying the story, while group gross margin reached 70.5%. Non GAAP net income attributable...

Simcere Pharmaceutical Group stock has drifted over the past month, down about 9%, even as the latest half year results land with a very different message. The headline is margin power. Net margin for the current period sits at 18% compared with 12.4% a year earlier, and trailing 12 month earnings now reflect a 78.6% yearly jump. The market still prices Simcere Pharmaceutical Group on a P/E of 16.9x, above local pharma peers. However, the company’s own cash flow estimate points to value above...

Zhong An Intelligent Living Service closed at HK$2.91 after a weak recent run, with the stock down over the past week and month even before investors digested the latest earnings. The headline today is not revenue, which sits at C¥237.969m for the half, but profit quality. Net income for H1 2026 came in at C¥8.85m with basic earnings per share of C¥0.0166. Against a rich 46.8x P/E and a discounted cash flow value of HK$0.69 per share, that profit squeeze is what is really testing market...

Linklogis walked into this earnings day with the stock up 15% over the past month, trading at HK$2.30 and priced as a growth story in Hong Kong fintech. The market has been paying a premium P/S multiple for that story. The headline from H1 2026 is simple. The company moved back to a small profit, with basic earnings per share of CNY0.01 and net income of CNY23.936m, after a series of losses. For a stock built on future promises, this shift toward profitability is what matters most right...

3SBio stock closed at HK$17.83 on Friday, roughly flat over the past month, even as the latest half year numbers landed with a heavy focus on profitability. The headline is simple. H1 2026 brought in C¥4,525.985m of revenue, yet the story that matters is margin strength and what that might mean for future earnings power. Investors now face a time horizon test. Trailing earnings growth and a P/E around 4.6x paint one picture. Forecasts that point to declining revenue and earnings over the next...

AAC Technologies Holdings entered this earnings release with a stock that had drifted in recent months, with the share price down about 7% over 90 days, yet expectations for solid growth still firmly in place. The headline from H1 2026 is straightforward. Revenue reached ¥14,506.4m and basic earnings per share came in at ¥0.79, keeping the trailing twelve month earnings picture intact and consistent with the recent 18.8% yearly earnings growth history. For a hardware supplier tied closely to...

The market has treated Henderson Land Development as a slow burn value play in Hong Kong property, but the latest earnings have produced a sharper story than that reputation suggests. The stock closed at HK$30.20 on 21 August, after a modestly positive month, while the new half year numbers show earnings strength sitting inside a richer valuation. The headline is simple. Henderson Land Development delivered higher half year earnings on a revenue base of HK$17,203 million. The trailing 12...

BOC Aviation went into these results with the stock drifting, down about 4% over the past month to HK$73.05, even though the P/E multiple sat well below peers. The new half year numbers keep that expectation gap wide open. Revenue for the first half reached about US$1.21b and basic earnings per share came in at roughly US$0.51. However, the real story is pressure on earnings quality as interest coverage remains weak while dividends strain free cash flow. Is BOC Aviation a genuine value...

Blue Moon Group Holdings stock has been grinding higher in recent weeks, yet the latest half year numbers land as a reality check on profitability. The company posted a loss in H1 2026 with basic earnings per share at HK$0.0366 in the red on revenue of HK$2,882.8m. That keeps the trailing twelve month net result in loss territory and leaves the dividend looking exposed given it is not covered by earnings or free cash flow. The market now has to decide whether today’s price strength reflects...

Hua Medicine (Shanghai) stock closed at HK$2.60 on Friday, roughly flat over the past month but still down about 20% over three months. The market reaction looks cautious. The headline from these H1 2026 numbers is a clear margin and profit squeeze. Revenue reached CNY 378.9m, yet the company still reported a net loss of CNY 30.2m and a trailing twelve month loss of CNY 107.8m. For a commercial stage biotech built around dorzagliatin, that gap between a growing top line and continuing losses...

Traders came into today riding a hot tape on Mongolian Mining, with the stock up about 46% over the past month and 11% over the past week into the H1 2026 earnings release. The headline is simple: profitability is doing the heavy lifting, while valuation is where the real tension now sits. H1 net income of US$88.98 million on US$586.23 million of revenue feeds into a trailing net margin of 11.1%, above last year’s 9.7%, and a P/E of 11.7x that sits below both the Hong Kong metals and mining...

Bank of Chongqing stock has quietly inched higher in recent weeks, yet today’s earnings story is less about the share price drift and more about how the balance sheet is holding up. The headline is that profit remains solid while the pressure point sits on asset quality. Quarterly net income came in at C¥1,724.4m on revenue of C¥3,258.5m, and trailing net profit margin sits near 49%. That looks healthy on the surface, but non performing loans are now reported at C¥6,259m. For a regional...